A recent randomized controlled clinical trial with 5-year follow-up demonstrates the impressive effectiveness of the combination of metabolic surgery with medical therapies and shifts the paradigm in the care of patients with obesity and type 2 diabetes mellitus.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ikramuddin, S. et al. Lifestyle intervention and medical management with versus without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study. JAMA 319, 266–278 (2018).
Reges, O. et al. Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy versus usual care obesity management with all-cause mortality. JAMA 319, 279–290 (2018).
Sjostrom, L. et al. Bariatric surgery and long-term cardiovascular events. JAMA 307, 56–65 (2012).
Lean, M. E. J. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541–551 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.W.l.R is on the advisory boards for Johnson & Johnson, Fractyl, GI, Dynamics, NovoNordisk and Herbalife. A.M has received research grants or honoraria from Fractyl, Johnson & Johnson, NovoNordisk, Astrazeneca and Boehringer Ingelheim
Rights and permissions
About this article
Cite this article
Miras, A., le Roux, C. The new gold-standard — medical gastric bypass. Nat Rev Endocrinol 14, 257–258 (2018). https://doi.org/10.1038/nrendo.2018.28
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2018.28
This article is cited by
-
PBPK modeling of CYP3A and P-gp substrates to predict drug–drug interactions in patients undergoing Roux-en-Y gastric bypass surgery
Journal of Pharmacokinetics and Pharmacodynamics (2020)
-
Body weight-dependent and independent improvement in lipid metabolism after Roux-en-Y gastric bypass in ApoE*3Leiden.CETP mice
International Journal of Obesity (2019)